Abstract
There was studied the level of matrix metalloproteinase-9 (MMP-9) in plasma of bone marrow aspirates in 87 patients: 39 with acute myeloid leukemia (AML) and 48 myelodysplastic syndrome (MDS). It has been found out an association of the level of MMP-9 in plasma of bone marrow aspirates in patients with AML and MDS with a volume of leukemic mass.References
Лесниченко И. Ф., Грицаев С.В., Капустин С.И. Матриксные металло-протеиназы: характеристика, роль в лейкозогенезе и прогностическое значение // Вопр. онкол. -2011. - Т. 57. - № 3. - С. 286-294.
Лесниченко И. Ф., Грицаев С.В., Сергеев А.Н., Кострома И.И. Активность матриксных металлопротеиназ ММП-2 и ММП-9 в плазме аспиратов костного мозга больных острым миелоидным лейкозом //Биомед. химия.- 2013. - Т. 59. - № 5. - С. 578-584.
Лесниченко И.Ф., Грицаев С.В., Кострома И.И. Матриксные металлопротеиназы-2 и -9 в плазме аспиратов костного мозга больных острым миелоидным лейкозом // Бюлл. Сиб. отд. росс. акад. мед. наук. - 2014. - Т. 6. - № 34. - С. 13-18.
Chaundary A.K., Pandya S., Ghoh K., Nadkarni A. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview // Mutat Res. - 2013. - Vol. 1. - № 753. - P 7-23.
Cheson B.D., Bennett J.M., Kopecky K.J. et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia // J Clin Oncol. - 2003. - Vol. 21. - N 24. - P. 4642-4649.
Cheson B.D., Greenberg P.L., Bennett J.M. et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia // Blood. - 2006. - Vol. 108. - № 2. - P. 419-425.
Gialeli C., Theocharis A.D., Karamanos N.K. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting // FEBS J. - 2011. - Vol. 276. - № 1. - P. 16-27.
Greenberg P., Cox C., LeBeau M.M. et al. International scoring system for evaluating prognosis in myelodysplastic syndromes // Blood. - 1997. - Vol. 89. - № 6. - P. 2079-2088.
Lin L., Lin D.T., Chang C.J., Lee C.Y et al. Marrow matrix mealloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: potential role of MMP-9 as a surrogate marcer to monitor leukaemic status in patients with acute myelogenous leukaemia // Br J Haematol. - 2002. - Vol. 117. - № 4. - P. 835-841.
Manello F., Medda V. Nuclear localization of matrix metalloproteinases. // Prog Histochem Cytochem. - 2012. - № 47. - № 1. - P. 27-58.
Ries C., Loher F., Zang C. et.al. P.E. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes // Clin Canser Res. - 1999. - Vol. 5. - № 5. - P. 1115-1124.
Vardiman J.W., Thiele J., Arber D.A. et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes // Blood. - 2009. -Vol. 114. - № 5. - P 937-951.
Yu X.F., Han Z.C. Matrix metalloproteinases in bone marrow: roles of gelatinases in physiological hematopoiesis and hematopoietic malignancies // Histol Histopatol. - 2006. - Vol. 21. - № 5. - P 519-531.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...